Patents by Inventor Emmanuel Deval

Emmanuel Deval has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8357659
    Abstract: The invention relates to the use of the peptide toxin APETx2 that blocks the ASIC3 cationic channels and that is derived from the Anthopleura elegantissima sea anemone, and to the use of the analogs and derivatives thereof as a drug, particularly as an analgesic pain associated with the activation of ASIC3 (Acid Sensing Ion Channel 3) channels, in particular pain occurring upon an inflammation and potentially upon any painful situation associated with tissue acidosis (ischemiae, fractures, hematoma, oedema, phlyctena, local infections, tissue lesions, ocular wounds, tumours, etc.).
    Type: Grant
    Filed: June 4, 2009
    Date of Patent: January 22, 2013
    Assignees: Centre National de la Recherche Scientifique-CNRS, Universite Nice Sophia Antipolis
    Inventors: Emmanuel Deval, Sylvie Diochot, Michel Lazdunski, Eric Lingueglia, Jacques Noel
  • Publication number: 20110152197
    Abstract: The invention relates to the use of the peptide toxin APETx2 that blocks the ASIC3 cationic channels and that is derived from the Anthopleura elegantissima sea anemone, and to the use of the analogs and derivatives thereof as a drug, particularly as an analgesic pain associated with the activation of ASIC3 (Acid Sensing Ion Channel 3) channels, in particular pain occurring upon an inflammation and potentially upon any painful situation associated with tissue acidosis (ischemiae, fractures, hematoma, oedema, phlyctena, local infections, tissue lesions, ocular wounds, tumours, etc.
    Type: Application
    Filed: June 4, 2009
    Publication date: June 23, 2011
    Applicants: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE-CNRS-, UNIVERSITE NICE SOPHIA ANTIPOLIS
    Inventors: Emmanuel Deval, Sylvie Diochot, Michel Lazdunski, Eric Lingueglia, Jacques Noel